H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...

Viking Therapeutics Inc. dropped its share prices by 7.34 percent on Monday to end at $30.17 apiece as investors reacted ...

In this article, we are going to take a look at where Viking Therapeutics Inc. (NASDAQ:VKTX) stands against the other stocks. Wall Street's major indices kicked off the trading on a positive note ...

In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that took a nosedive in January. Historically, the S&P 500’s performance ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares traded down 4.9% on Monday after Maxim Group lowered their price target on the stock from $120.00 to $70.00.Maxim Group currently ...

Raymond James analyst Steven Seedhouse raised the firm’s price target on Viking Therapeutics (VKTX) to $125 from $122 and keeps a Strong Buy ...

KBC Group NV grew its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 41.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC.

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared ...